This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Il Dong Pharmaceutical Co., Ltd.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Jongmin Yoon: Innovator in CFTR Modulation
Introduction
Jongmin Yoon is a notable inventor based in Hwaseong, South Korea. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that modulate the cystic fibrosis transmembrane conductance regulator (CFTR).
Latest Patents
Jongmin Yoon holds a patent for "Substituted pyrazolo[1,5-a]pyrimidines as CFTR modulators." This patent provides CFTR modulator and phosphodiesterase 4 (PDE4) inhibitor compounds, which can be utilized for treating eye diseases and CFTR-related indications. The patent also outlines methods for using these compounds to inhibit PDE4 in biological systems, addressing inflammatory diseases and disorders.
Career Highlights
Yoon's career is marked by his innovative approach to drug development. His work has led to advancements in therapies that target CFTR-related conditions, showcasing his commitment to improving patient outcomes through scientific research.
Collaborations
Jongmin Yoon has collaborated with esteemed colleagues, including Myongjae Lee and Changmok Oh. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic compounds.
Conclusion
Jongmin Yoon's contributions to the field of CFTR modulation exemplify the impact of innovative research in pharmaceuticals. His work continues to pave the way for new treatments that address critical health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile